NOV vs SLB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

NOV

44.9
AI Score
VS
NOV Wins

SLB

39.8
AI Score

Investment Advisor Scores

NOV

45score
Recommendation
HOLD

SLB

40score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NOV SLB Winner
Revenue 2.05B 17.69B SLB
Net Income 19.00M 1.54B SLB
Net Margin 0.9% 8.7% SLB
ROE 0.3% 5.9% SLB
ROA 0.2% 2.8% SLB
Total Assets 11.14B 55.53B SLB
Cash 1.34B 2.74B SLB
Debt/Equity 0.28 0.43 NOV
Current Ratio 2.47 1.44 NOV
Free Cash Flow -91.00M 1.04B SLB

Relative Price Performance (Last 90 Days)

NOV 1M: +1.4% · 3M: -2.1% SLB 1M: +14.1% · 3M: -5.9%

Current Technical Phase

NOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.0 · Price: $20.42

SLB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 61.2 · Price: $53.87

Fundamentals Snapshot

Metric NOV SLB
Market Cap
Forward P/E 16.2 16.6
Trailing P/E 78.0 26.0
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 0.26 2.06
Dividend Yield 0.02% 0.02%

Frequently Asked Questions

Based on our detailed analysis, NOV is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.